Design
Review
Authors
Loading...
TEHV may enable growth-compatible valves in children; leaves open clinical translation pending prospective trials.
Tissue-engineered heart valves remain a promising future technology for reconstructive surgery but currently lack successful clinical translation.
Shinoka et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: